Engaging Key Opinion Leaders (KOLs) - Identifying and Leveraging New KOL Groups to Drive Medical Marketing Strategy - GBI Research Reports

Engaging Key Opinion Leaders (KOLs) - Identifying and Leveraging New KOL Groups to Drive Medical Marketing Strategy

Engaging Key Opinion Leaders (KOLs) - Identifying and Leveraging New KOL Groups to Drive Medical Marketing Strategy - GBI Research Reports
Engaging Key Opinion Leaders (KOLs) - Identifying and Leveraging New KOL Groups to Drive Medical Marketing Strategy
Published Sep 30, 2012
49 pages — Published Sep 30, 2012
Price US$ 3,500.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

GBI Research, the leading business intelligence provider, has released its latest research, Engaging Key Opinion Leaders (KOLs) - Identifying and Leveraging New KOL Groups to Drive Medical Marketing Strategy. This report examines the roles of Key Opinion Leaders (KOLs) within the pharmaceutical industry now and in the future. It looks at the roles traditionally held by KOLs. It describes the consequences of the changing healthcare environment on how the industry identifies and works with new groups of key opinion leaders, examining three areas of particular importance for KOL management within the pharmaceutical industry today. Firstly, the report will investigate the emerging trend to externalize research and to establish productive relationships with academic laboratories and principal investigators. Secondly, it will analyze the landscape for the traditional KOL the healthcare professional detailing changes to Codes of Practice guiding the pharmaceutical industrys interactions with these individuals, trends in KOL management, and issues of relevance to emerging markets. Finally, the report considers the role of patients and their advocates in providing insights that should drive drug discovery and development in the future.

The report is built using information from primary and secondary research, including interviews with experts in the field.

GBI Research analysis shows that the pharmaceutical industry is facing a number of challenges that will influence the way it works with KOLs. The costs of R&D are rising as clinical development programs become longer and more complex, while industry revenues are falling. Companies have cut their internal workforces and are now looking externally for new products. The pressure on healthcare budgets from growing and ageing populations and the rise in non-communicable diseases, such as cardiovascular disease and different cancers, as well as the increasing costs of some medicines, have led healthcare providers to pay much greater attention to the cost-effectiveness of new products as a condition of reimbursement. As a consequence, the focus on marketing medicines in emerging economies has also increased. These changes require reevaluation of the role of the KOL as new groups of thought leaders are considered highly influential to the future of the industry.

Scope

- Detailed analysis of the changes in the industry and healthcare environment that are causing new groups of KOLs to emerge
- Exploration of the influence of academic scientists on industry R&D as companies look to externalize more of their research
- Detailed insights into the changing nature of the relationship of the industry with healthcare professionals, including details of the current compliance environment
- Examination of the role of patients in driving drug development within the industry
- Study of the growing importance of online social networks in each of these areas
- Investigation of how to identify and build successful relationships with these emerging groups of KOLs

Reasons to buy

- Identify key groups that are considered influential for the future of the industry.
- Develop strategies and priorities for engaging with these new groups of KOLs
- Learn the most important methods for identifying influential people and building effective relationships with them
- Understand how the changing compliance environment will affect industry relationships with healthcare professionals
- Explore why patients are becoming more influential and how to engage with this important group

  
Source:
Document ID
GBIHC262MR
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents52
  List of Tables61
  List of Figures61
Introduction78
  Key Opinion Leaders: A History71
  Established KOL Roles in Drug Discovery, Development and Marketing82
  The Changing Environment for the Pharmaceutical Industry101
    Market Access: Reimbursement Authorities101
    Market Access: Purchasing111
    Generic and Specialty Medicines111
    Emerging Markets121
    Big Data: the Changing Environment for Science and Medicine131
    Emerging Business Models131
  Emerging KOL Roles141
Building Relationships for External Innovation158
  Introduction151
  Growth Close to Hubs and Clusters151
  Working with Academia161
    Pfizer s Centers for Therapeutic Innovation171
    The California Institute for Biomedical Research181
  New Funding Models to Support Innovation181
  Drug Development Relationships191
  Key Opinion Leaders in the Emerging Drug Discovery and Development Landscape: Finding Experts191
    Knode201
  Key Opinion Leaders in the Emerging Drug Discovery and Development Landscape: Building Relationships211
  Conclusions221
Building Relationships with Healthcare Professionals2312
  Introduction231
  Identifying KOLs and Building Relationships241
    KOL Management251
  Healthcare Engagement: Codes of Practice261
    US261
    The Office of Inspector General Guidelines271
      The Pharmaceutical Research and Manufacturers Association Codes of Practice272
    EU291
  KOLs in Emerging Markets301
    Emerging Markets: Compliance Environment301
  Key Opinion Leaders Online301
    Examples of Best Practice in Digital Engagement311
    Channels for Engaging Healthcare Professionals Online321
    Digital Literacy321
    Regulating online engagement331
  Evolution of KOL Interactions341
Building Relationships with Patients3510
  Introduction351
  Patients Roles in Drug Development352
  Overcoming Barriers to Effective Engagement371
    Increasing Patients Awareness of the Clinical Research Process371
    Ethical Principles for Working with Patients371
    Transparency381
  Gaining Insights from Patients381
    Patients Online391
    Working with Online Patient Communities401
      PatientsLikeMe.com401
      CureTogether.com411
    Patient Intelligence421
      PIP Health421
  Clinical Trial Recruitment431
  Venture Philanthropy431
  Conclusions441
Appendix455
  Abbreviations451
  References453
  Research Methodology482
    Coverage481
    Secondary Research481
    Primary Research491
    Expert Panel Validation491
  Contact Us491
  Disclaimer491

Table Of Contents

GBI Research Reports—GBI Research covers worldwide markets and issues, supplies actionable data and forecasts and is driven by industry leaders' insights. GBI Research provides a broad spectrum of reports across the healthcare and energy industries and its online offering is easy to navigate - a comprehensive resource for business information needs.

About the Author


Cite this Report

  
MLA:
GBI Research Reports. "Engaging Key Opinion Leaders (KOLs) - Identifying and Leveraging New KOL Groups to Drive Medical Marketing Strategy" Sep 30, 2012. Alacra Store. Nov 15, 2026. <http://www.alacrastore.com/storecontent/GBI-Research-Reports/Engaging-Key-Opinion-Leaders-KOLs-Identifying-and-Leveraging-New-KOL-Groups-to-Drive-Medical-Marketing-Strategy-2115-500>
  
APA:
GBI Research Reports. (2012). Engaging Key Opinion Leaders (KOLs) - Identifying and Leveraging New KOL Groups to Drive Medical Marketing Strategy Sep 30, 2012. New York, NY: Alacra Store. Retrieved Nov 15, 2026 from <http://www.alacrastore.com/storecontent/GBI-Research-Reports/Engaging-Key-Opinion-Leaders-KOLs-Identifying-and-Leveraging-New-KOL-Groups-to-Drive-Medical-Marketing-Strategy-2115-500>
  
US$ 3,500.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.